RVMD logo

RVMD
Revolution Medicines Inc

2,028
Mkt Cap
$29.54B
Volume
4.28M
52W High
$155.70
52W Low
$34.00
PE Ratio
-22.73
RVMD Fundamentals
Price
$134.48
Prev Close
$141.50
Open
$141.79
50D MA
$106.78
Beta
1.11
Avg. Volume
1.93M
EPS (Annual)
-$5.95
P/B
16.24
Rev/Employee
$0.00
$13,545.26
Loading...
Loading...
News
all
press releases
M&T Bank Corp Acquires New Holdings in Revolution Medicines, Inc. $RVMD
M&T Bank Corp acquired a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission...
MarketBeat·20h ago
News Placeholder
More News
News Placeholder
Leerink Partners Boosts Revolution Medicines (NASDAQ:RVMD) Price Target to $171.00
Leerink Partners lifted their price target on shares of Revolution Medicines from $147.00 to $171.00 and gave the stock an "outperform" rating in a research note on Wednesday...
MarketBeat·2d ago
News Placeholder
HC Wainwright Reiterates "Buy" Rating for Revolution Medicines (NASDAQ:RVMD)
HC Wainwright reissued a "buy" rating and issued a $169.00 price target on shares of Revolution Medicines in a report on Wednesday...
MarketBeat·2d ago
News Placeholder
Revolution Medicines, Inc. (NASDAQ:RVMD) Receives Average Rating of "Buy" from Brokerages
Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) has earned a consensus recommendation of "Buy" from the twenty-one ratings firms that are currently covering the firm, MarketBeat.com...
MarketBeat·2d ago
News Placeholder
Mass General Brigham Inc Takes Position in Revolution Medicines, Inc. $RVMD
Mass General Brigham Inc purchased a new position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC...
MarketBeat·3d ago
News Placeholder
Revolution Medicines (NASDAQ:RVMD) Earns "Buy" Rating from Stifel Nicolaus
Stifel Nicolaus reaffirmed a "buy" rating and set a $215.00 price target (up from $170.00) on shares of Revolution Medicines in a report on Monday...
MarketBeat·4d ago
News Placeholder
Revolution Medicines (NASDAQ:RVMD) Insider Sells $18,010,800.00 in Stock
Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Mark Goldsmith sold 120,000 shares of the company's stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $150.09, for a total transaction of $18,010,800.00. Following the completion of the...
MarketBeat·6d ago
News Placeholder
Insider Selling: Revolution Medicines (NASDAQ:RVMD) Insider Sells 120,000 Shares of Stock
Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Mark Goldsmith sold 120,000 shares of Revolution Medicines stock in a transaction dated Wednesday, April 15th. The shares were sold...
MarketBeat·6d ago
News Placeholder
Q4 EPS Forecast for Revolution Medicines Raised by Analyst
Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - Research analysts at Lifesci Capital upped their Q4 2026 EPS estimates for shares of Revolution Medicines in a report issued on Monday, April 13th. Lifesci Capital analyst C. Zhu now forecasts that the company will post earnings of ($2.08) per...
MarketBeat·8d ago
News Placeholder
Medical Stocks To Watch Now - April 15th
Eli Lilly and Company, Revolution Medicines, and UnitedHealth Group are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of companies...
MarketBeat·9d ago
<
1
2
...
>

Latest RVMD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.